Anders Kjellman

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF UROLOGY. 2024;212(5):720-730
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
Thor A; Myklebust MP; Bergdahl AG; Lundgren P-O; Skokic V; Almas B; Haugnes HS; Tandstad T; Akre O; Cohn-Cedermark G; Dahl O; Kjellman A
Journal article: CURRENT ONCOLOGY. 2024;31(9):5318-5329
Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses
Zinko G; Hrebenyuk M; Kjellman A; Forslin Y; Delle M
Article: BJU INTERNATIONAL. 2024;133(6):717-724
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
Gerdtsson A; Negaard HFS; Almas B; Bergdahl AG; Cohn-Cedermark G; Glimelius I; Halvorsen D; Haugnes HS; Hedlund A; Hellstrom M; Holmberg G; Karlsdottir A; Kjellman A; Larsen SM; Thor A; Wahlqvist R; Stahl O; Tandstad T
Article: CURRENT ONCOLOGY. 2024;31(2):933-940
Ablative or Surgical Treatment for Small Renal Masses (T1a): A Single-Center Comparison of Perioperative Morbidity and Complications
Radros J; Kjellman A; Henningsohn L; Forslin Y; Delle M; Hrebenyuk M; Thor A; Thiel T; Hermann M; Lundgren P-O
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2023;57(1-6):67-74
Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register
Almdalal T; Rosenblad AK; Hellstrom M; Kjellman A; Lindblad P; Lundstam S; Sundqvist P; Ljungberg B
Journal article: PANCREATOLOGY. 2023;23:e25
Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis
Vujasinovic M; Dugic A; Thiel T; Kjellman A; Yang C; Löhr J-M
Article: BJU INTERNATIONAL. 2023;132(3):329-336
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
Gerdtsson A; Torisson G; Thor A; Bergdahl AG; Almas B; Hakansson U; Tornblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):5008
Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne.
Tandstad T; Kjellman A; Almås B; Grenabo Bergdahl A; Cohn-Cedermark GE; Gerdtsson A; Glimelius I; Halvorsen DL; Haugnes HSS; Hedlund A; Karlsdottir A; Larsen SM; Negaard HFS; Pfister D; Stahl O; Thor A; Wahlquist R; Heidenreich A; Paffenholz P; Seelemeyer F
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e617
MP44-15 THE VALUE OF PROSTATE-SPECIFIC ANTIGEN DENSITY IN LONG-TERM PROSTATE CANCER-MORTALITY RISK PREDICTION
Yacoub SY; Lundgren P-O; Kjellman A; Gustafsson O
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e451
MP33-04 THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3cm
Thor A; Gerdtsson A; Almas B; Halvorsen D; Cedermark GC; Neegaard H; Glimelius I; Haugnes HS; Karlsdottir A; Stahl O; Larsen SM; Bergdahl AG; Tandstad T; Kjellman A
Article: PANCREATOLOGY. 2023;23(3):294-298
Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis
Vujasinovic M; Dugic A; Thiel T; Kjellman A; Yang C; Lohr J-M
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(6):5160
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer
Tribukait B; Lundgren P-O; Kjellman A; Norming U; Nyman CR; Jagarlmundi K; Gustafsson O
Journal article: EUROPEAN UROLOGY. 2023;83:s1728
A1195 The value of prostate-specific antigen density in long-term prostate cancer-mortality risk prediction
Yacoub SY; Lundgren P; Kjellman A; Gustafsson O
Journal article: EUROPEAN UROLOGY. 2023;83:s1072
Low rate of teratoma in primary retroperitoneal lymph node dissection for non-seminoma csiia marker negative patients - a population-based study from the swedish and norwegian testicular cancer group
Gerdtsson A; Thor AT; Grenabo BAGB; Almas BA; Negaard HF; Glimelius I; Halvorsen DH; Karlsdottir AK; Haugnes HSH; Larsen SML; Holmberg GH; Wahlqvist RW; Tandstad TT; Cohn-Cedermark GCC; Kjellman AK; Stahl OS
Journal article: EUROPEAN UROLOGY. 2023;83:s1068
The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm
Thor A; Grenabo BA; Almas B; Halvorsen D; Cohn CG; Neegaard H; Karlsdottir A; Sagstuen HH; Stahl O; Gerdtsson A; Melsen LS; Tandstad T; Kjellman A
Article: CLINICAL GENITOURINARY CANCER. 2023;21(1):107.e1-107.e9
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
Stattin P; Westerberg M; Lissbrant IF; Eriksson MH; Kjellman A; Ullen A; Vassilev Z; Sandstrom P; Weinrib R; Martinez D; Garcia-Albeniz X
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(5-6):383-390
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma
Rosenblad AK; Sundqvist P; Harmenberg U; Hellstrom M; Hofmann F; Kjellman A; Dahlin B-IK; Lindblad P; Lindskog M; Lundstam S; Ljungberg B
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;40:38-45
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study
Lindskog M; Laurell A; Kjellman A; Melichar B; Rey PM; Zielinski H; Villacampa F; Bigot P; Zoltan B; Parikh O; Alba DV; Jellvert D; Flasko T; Gallardo E; Caparros MJR; Purkalne G; Suenaert P; Karlsson-Parra A; Ljungberg B
Article: PROSTATE. 2022;82(8):911-916
Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer
Lundgren P-O; Tribukait B; Kjellman A; Norming U; Jagarlmudi K; Gustafsson O
Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e845
PD51-07 PREDICTING THE HISTOPATHOLOGY RESULT OF POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)
Gerdtsson A; Thor A; Bergdahl AG; Negaard H; Almås B; Glimelius I; Karlsdottir Å; Halvorsen D; Andreassen KE; Larsen SM; Wahlqvist R; Haugnes HS; Tandstad T; Holmberg G; Cedermark GC; Ståhl O; Thorison G; Kjellman A
Article: EUROPEAN UROLOGY ONCOLOGY. 2022;5(2):235-243
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Gerdtsson A; Thor A; Bergdahl AG; Almas B; Hakansson U; Tornblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Article: CANCER. 2021;127(21):4050-4058
Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator-mandated cohort postauthorization safety study in Denmark, Norway, and Sweden
Ehrenstein V; Heide-Jorgensen U; Schiodt M; Akre O; Herlofson BB; Hansen S; Wexell CL; Norholt SE; Tretli S; Kjellman A; Glennane A; Lowe KA; Sorensen HT
Article: BJU INTERNATIONAL. 2021;128(4):490-496
Association between one-time prostate-specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30-year prospective cohort study
Lundgren P-O; Kjellman A; Norming U; Gustafsson O
Article: SCIENTIFIC REPORTS. 2021;11(1):15582
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Myklebust MP; Thor A; Rosenlund B; Gjengsto P; Karlsdottir A; Brydoy M; Bercea BS; Olsen C; Johnson I; Berg MI; Langberg CW; Andreassen KE; Kjellman A; Haugnes HS; Dahl O
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(6):487-492
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting
Ljungberg B; Sundqvist P; Lindblad P; Kjellman A; Thorstenson A; Hellstrom M; Dahlin B-IK; Thomasson M; Harmenberg U; Lundstam S
Article: PROSTATE. 2020;80(10):777-781
Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study
Lundgren P-O; Kjellman A; Norming U; Gustafsson O
Article: EUROPEAN UROLOGY ONCOLOGY. 2020;3(3):382-389
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Gerdtsson A; Hakansson U; Tornblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Journal article: INVESTIGATIVE UROLOGY. 2020;203:e384
PD19-06 LOCATION AND HISTOLOGY OF RETROPERITONEAL METASTASES IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMA GERM CELL TUMOUR
Gerdtsson A; Thor* A; Grenabo A; Almås B; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(5_suppl):11
A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous metastatic renal cell carcinoma.
Lindskog M; Laurell A; Kjellman A; Melichar B; Niezabitowski J; Maroto P; Zieliński H; Villacampa F; Bigot P; Bajory Z; Parikh O; Vazquez Alba D; Jellvert A; Flasko T; Gallardo Diaz E; Ribal MJ; Purkalne G; Suenaert P; Karlsson-Parra A; Ljungberg B
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2019;53(4):235-239
Reduced bleeding with DRY CUT® transurethral resection of the prostate (TURP) compared to standard TURP
Sjostrom C; Bergkvist M; Thulin H; Kjellman A; Thorstenson A
Article: JOURNAL OF UROLOGY. 2018;200(1):82-88
Long-Term Outcome of a Single Intervention Population Based Prostate Cancer Screening Study
Lundgren P-O; Kjellman A; Norming U; Gustafsson O
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2018;378(15):1408-1418
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Smith MR; Saad F; Chowdhury S; Oudard S; Hadaschik BA; Graff JN; Olmos D; Mainwaring PN; Lee JY; Uemura H; Lopez-Gitlitz A; Trudel GC; Espina BM; Shu Y; Park YC; Rackoff WR; Yu MK; Small EJ
Journal article: INVESTIGATIVE UROLOGY. 2018;199(4):e498
MP37-17 COMPLICATIONS OF POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED TESTICULAR CANCER
Gerdtsson A; Håkansson U; Holmberg G; Halvorsen D; Wahlqvist R; Haugnes H; Tandstad T; Ståhl O; Cohn-Cedermark G; Kjellman A
Article: ANNALS OF ONCOLOGY. 2016;27(7):1299-1304
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
Tandstad T; Stahl O; Dahl O; Haugnes HS; Hakansson U; Karlsdottir A; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Soderstrom K; Stierner U; Cavallin-Stahl E; Wahlqvist R; Wall N; Cohn-Cedermark G
Article: CLINICAL EPIDEMIOLOGY. 2016;8:267-272
Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
Acquavella J; Ehrenstein V; Schiodt M; Heide-Jorgensen U; Kjellman A; Hansen S; Wexell CL; Herlofson BB; Noerholt SE; Ma H; Ohrling K; Hernandez RK; Sorensen HT
Article: ACTA ONCOLOGICA. 2015;54(4):493-499
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols
Tandstad T; Solberg A; Hakansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2013;47(4):265-271
Treatment with finasteride and prostate cancer survival
Kjellman A; Friis S; Granath F; Gustafsson O; Sorensen HT; Akre O
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15_suppl):4508
Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma.
Tandstad T; Solberg A; Hakansson U; Angelsen A; Haugnes HS; Oldenburg J; Kjellman A; Dahl O; Cohn-Cedermark G
Article: JOURNAL OF INTERNAL MEDICINE. 2011;269(3):299-305
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
Kjellman A; Akre O; Gustafsson O; Hoyer-Hansen G; Lilja H; Norming U; Piironen T; Tornblom M
Article: PROSTATE. 2010;70(2):200-205
Radical Prostatectomy: Influence on Serum and Urinary Androgen Levels
Olsson M; Ekstrom L; Schulze J; Kjellman A; Akre O; Rane A; Gustafsson O
Article: JOURNAL OF UROLOGY. 2009;181(4):1615-1621
15-Year Followup of a Population Based Prostate Cancer Screening Study
Kiellman A; Akre O; Norming U; Tornblom M; Gustafsson O
Article: EUROPEAN UROLOGY. 2008;53(1):106-111
Dihydrotestosterone levels and survival in screening-detected prostate cancer:: A 15-yr follow-up study
Kiellman A; Akre O; Norming U; Toernblom M; Gustafsson O
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2006;5(2):319
IS DIHYDROTESTOSTERON A PROGNOSTIC FACTOR AMONG MEN WITH SCREENING-DETECTED PROSTATE CANCER?
Kjellman A; Akre O; Norming U; Tornblom M; Gustafsson O
Visa fler

Alla övriga publikationer

Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)
Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.
Heidenreich A; Daneshmand S; Che Y; Pfister DA; Paffenholz P; Ghoreifi A; Zschaebitz S; Hentrich M; Thy S; Albers P; Cary C; Gerdtsson A; Kjellman A; Negaard HFS
Review: JOURNAL OF CLINICAL MEDICINE. 2023;12(19):6340
Autoimmune Pancreatitis Type 1 with Biliary, Nasal, Testicular, and Pulmonary Involvement: A Case Report and a Systematic Review
Kourie M; Bogdanovic D; Mahmutyazicioglu K; Ghazi S; Panic N; Fjellgren E; Hellkvist L; Thiel T; Kjellman A; Kartalis N; Danielsson O; Dani L; Lohr J-M; Vujasinovic M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)
Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne
Tandstad T; Kjellman A; Almas B; Bergdahl AG; Cohn-Cedermark GE; Gerdtsson A; Glimelius I; Halvorsen DL; Haugnes HSS; Hedlund A; Karlsdottir A; Larsen SM; Negaard HFS; Pfister D; Stahl O; Thor A; Wahlquist R; Heidenreich A; Paffenholz P; Seelemeyer F
Conference publication: JOURNAL OF UROLOGY. 2023;209:E617-E618
THE VALUE OF PROSTATE-SPECIFIC ANTIGEN DENSITY IN LONG-TERM PROSTATE CANCER-MORTALITY RISK PREDICTION
Yacoub SY; Lundgren P-O; Kjellman A; Gustafsson O
Conference publication: JOURNAL OF UROLOGY. 2023;209:E451
THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3CM
Thor A; Gerdtsson A; Almas B; Halvorsen D; Cedermark GC; Neegaard H; Glimelius I; Haugnes HS; Karlsdottir A; Stahl O; Larsen SM; Bergdahl AG; Tandstad T; Kjellman A
Letter: BJU INTERNATIONAL. 2022;129(3):419
Association between total prostate-specific antigen (tPSA), free/tPSA, and prostate cancer mortality Reply
Lundgren P-O; Kjellman A; Norming U; Gustafsson O
Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E845
PREDICTING THE HISTOPATHOLOGY RESULT OF POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)
Gerdtsson A; Thor A; Bergdahl AG; Negaard H; Almas B; Glimelius I; Karlsdottir A; Halvorsen D; Andreassen KE; Larsen SM; Wahlqvist R; Haugnes HS; Tandstad T; Holmberg G; Cedermark GC; Stahl O; Thorison G; Kjellman A
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(5)
A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous metastatic renal cell carcinoma
Lindskog M; Laurell A; Kjellman A; Melichar B; Niezabitowski J; Maroto P; Zielinski H; Villacampa F; Bigot P; Bajory Z; Parikh O; Alba DV; Jellvert A; Flasko T; Diaz EG; Ribal MJ; Purkalne G; Suenaert P; Karlsson-Parra A; Ljungberg B
Conference publication: JOURNAL OF UROLOGY. 2020;203:E384
LOCATION AND HISTOLOGY OF RETROPERITONEAL METASTASES IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMA GERM CELL TUMOUR
Gerdtsson A; Thor A; Grenabo A; Almas B; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:461
Pharmacovigilance cohort study of osteonecrosis of the jaw and serious infection among cancer patients treated with denosumab or zoledronic acid in Denmark, Norway, and Sweden
Ehrenstein V; Heide-Jorgensen U; Schiodt M; Akre O; Herlofson BB; Hansen S; Wexell CL; Norholt SE; Tretli S; Kjellman A; Sorensen HT; Glennane A; Lowe K
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2019;53:21-22
Lymphadenectomy for urothelial carcinoma of the Ureter and Renal Pelvis (LURP-study)
Saemundsson YR; Baseckas G; Sorenby A; Brandstedt J; Kjellman A; Linnea L; Rian M; Jancke G; Liedberg F; Lundstrom KJ
Review: LAKARTIDNINGEN. 2018;115:E394
[Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].
Larsson Wexell C; Kjellman A; Akre O
Conference publication: JOURNAL OF UROLOGY. 2018;199(4):E498
COMPLICATIONS OF POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR ADVANCED TESTICULAR CANCER
Gerdtsson A; Hakansson U; Holmberg G; Halvorsen D; Wahlqvist R; Haugnes H; Tandstad T; Stahl O; Cohn-Cedermark G; Kjellman A
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15)
Bilateral testicular cancer within two prospective, population-based SWENOTECA protocols in clinical stage I nonseminoma
Tandstad T; Solberg A; Hakansson U; Angelsen A; Haugnes HS; Oldenburg J; Kjellman A; Dahl O; Cohn-Cedermark G
Meeting abstract: JOURNAL OF UROLOGY. 2011;185(4):e188
TREATMENT WITH 5-ALPHA REDUCTASE INHIBITORS AND PROSTATE CANCER SURVIVAL
Kjellman A; Friis S; Granath F; Gustafsson O; Sorensen HT; Akre O
Thesis / dissertation: 2010
Prostate cancer : aspects of screening and prognostic factors
Kjellman, Anders
Meeting abstract: JOURNAL OF UROLOGY. 2008;179(4):687
15-year follow-up of a randomised prostate-cancer screening study
Kjellman A; Akre O; Norming U; Tornblom M; Gustafsson O
Meeting abstract: JOURNAL OF UROLOGY. 2007;177(4):76
Dihydrotestosterone as a prognostic factor in men with screening-detected prostate cancer
Kjellman A; Akre O; Norming U; Tornblom M; Gustafsson O

Anställningar

Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2024-2027

Examina och utbildning

Docent, Urologi och njurmedicin, Karolinska Institutet, 2023
Medicine Doktorsexamen, Institutionen för klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2010
Läkarexamen, Karolinska Institutet, 1999

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI